Denmark's Genmab has decided not to continue the development of a drug for cancer, acasunlimab, which had reached phase 3 testing, after a review of its medicines pipeline. The decision to end the ...

A new project seeking to transform the drug delivery process and take projects out of “the valley of death” between aspiration and accomplishment is getting help from La Jolla-based medical research ...

Developing new drugs is not for the faint-hearted. “It’s a pretty perilous journey,” says Paul Nioi, vice-president of discovery and translational research at Alnylam Pharmaceuticals. “It’s expensive ...

WASHINGTON, DC—On Wednesday at the American Chemical Society Fall 2025 meeting, students and seasoned drug hunters alike gathered in a spacious third-floor ballroom of the Walter E. Washington ...